Miriam Beatriz Virgolini

Dr. Miriam Beatriz Virgolini

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2007 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
LWL.D. White
L.D. White
DCD.A. Cory-Slechta
D.A. Cory-Slechta
MGM.E. Gilbert
M.E. Gilbert
ETE. Tiffany-Castiglioni
E. Tiffany-Castiglioni
NZN.H. Zawia
N.H. Zawia
RBRiyaz Basha
Riyaz Basha

1 May 2004 in Environmental Health Perspectives
Verified
Journal Article
Open access
DCDeborah A Cory-Slechta
Deborah A Cory-Slechta
Miriam Beatriz VirgoliniMiriam Beatriz Virgolini
Miriam Beatriz Virgolini
MTMona Thiruchelvam
Mona Thiruchelvam
DWDoug D Weston
Doug D Weston
MBMark R Bauter
Mark R Bauter
Read the full review for this F1000Prime recommended article: Maternal stress modulates the effects of developmental lead exposure.

1 January 2021
Verified
Book Chapter
Closed access
Miriam Beatriz VirgoliniMiriam Beatriz Virgolini
Miriam Beatriz Virgolini
MAMichael Aschner
Michael Aschner

22 January 2008 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Closed access
PDF file
DCDeborah Cory-Slechta
Deborah Cory-Slechta
DADeborah A.
Deborah A.
Miriam Beatriz VirgoliniMiriam Beatriz Virgolini
Miriam Beatriz Virgolini
ARAlba Rossi‐George
Alba Rossi‐George
MTMona Thiruchelvam
Mona Thiruchelvam
DWDouglas Weston
Douglas Weston

27 July 2005 in Toxicological Sciences
Verified
Journal Article
Open access
PDF file
Miriam Beatriz VirgoliniMiriam Beatriz Virgolini
Miriam Beatriz Virgolini
KCKevin Chen
Kevin Chen
DWDoug D. Weston
Doug D. Weston
MBMark R. Bauter
Mark R. Bauter
DCDeborah A. Cory-Slechta
Deborah A. Cory-Slechta
Elevated lead (Pb) burden and high stress levels are co-occurring risk factors in low socioeconomic status (SES) children. Our previous work demonstrated that maternal Pb exposure can permanently alter hypothalamic-pituitary-adrenal (HPA) axis function and responsivity to stress challenges in offspring. The current study sought to determine the consequences of chronic Pb exposures initiated later in development combined with variable intermittent stress challenges. Male rats were exposed chronically from weaning to 0, 50, or 150 ppm Pb acetate drinking solutions (producing blood Pb levels of <5, 9–15, and 23–27 μg/dl, respectively). Pb itself decreased basal plasma corticosterone, with greater effects at 50 than 150 ppm; 150 ppm reduced both cytosolic and nuclear glucocorticoid receptor binding. Responsivity to stress challenges including novelty, cold, and restraint, was measured as changes in Fixed Interval (FI) schedule-controlled behavior in a subset of rats within each group. FI performance was modified by novelty stress only in Pb-treated rats, whereas cold and restraint stress effects were comparable across groups. Novelty elevated corticosterone equivalently across groups, but cold stress markedly increased corticosterone only in Pb-treated groups. The pattern of Pb-induced changes in serotonin (5-HT) or its metabolite 5-HIAA in frontal cortex, nucleus accumbens, striatum, and hypothalamus resembled that observed for basal corticosterone levels indicating a relationship between these variables. In addition to suggesting the potential for HPA axis-mediated effects of Pb on the central nervous system, these findings also raise questions about whether single chemicals studied in isolation from other relevant risk factors can adequately identify neurotoxic hazards.

1 January 2009 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
ARA. Rossi-George
A. Rossi-George
Miriam Beatriz VirgoliniMiriam Beatriz Virgolini
Miriam Beatriz Virgolini
DWD. Weston
D. Weston
DCDeborah Cory-Slechta
Deborah Cory-Slechta